Am I missing something? I don't think so. The drug sector in general has been getting hit hard, and the aborted Perrigo buyout this summer certainly didn't help. I continue to hold, as I think the shares are a good value under $14. I do wish I had sold in the mid-$20's though.On the bright side, the Forbes article this week naming Lannett #3 best small company in America seems to have generated some interest today.
Best Of |
Favorites & Replies |
Start a New Board |
My Fool |
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Rat